NEW YORK, July 10 – Lexicon Genetics said Tuesday it had extended and expanded a marketing collaboration with Oriental Yeast of Tokyo.
Under the terms of the deal, Oriental Yeast will help Lexicon Genetics of The Woodlands, Texas, to promote its LexVision Database of in vivo mammalian gene function to Japanese pharmaceutical companies. Oriental Yeast will also help to market Lexicon's drug target validation technologies in the Japanese market.
Financial terms of the agreement are not disclosed.
"The expansion of our contract with [Oriental Yeast] strengthens and confirms Lexicon's commitment to provide in vivo mammalian functional genomics and target validation to the Japanese drug discovery market," Randall Riggs, Lexicon's senior vice president of business development, said in a statement.
During the past year, Lexicon has worked with Oriental Yeast to develop a Japanese-language based website that allows researchers to access Lexicon's OmniBank library, which contains over 150,000 gene knockout clones, or more than 40 percent of all genes in the mammalian genome.
Oriental Yeast has been involved in the biotech industry since 1968. Four years ago, the company established the Nagahama Institute for Biochemical Sciences, a research center dedicated to researching and developing new compounds.